Evolus, Inc. (EOLS) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/26/21
Evolus, Inc. (EOLS) CEO David Moatazedi on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Evolus Announces Appointment of David K. Erickson as Vice President, Investor RelationsGlobeNewsWire • 06/30/21
Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of ColorGlobeNewsWire • 06/24/21
Evolus Appoints Dan Stewart as Vice President and General Manager, InternationalGlobeNewsWire • 05/19/21
Evolus, Inc. (EOLS) CEO David Moatazedi on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
Repeat Doses Of Evolus' Frown Lines Treatment Are Safe, With Decreasing Rates Of Adverse EventsBenzinga • 05/12/21
Allstate, Booking, CyberArk, Hilton and More Thursday Afternoon Analyst Calls24/7 Wall Street • 05/06/21
Evolus, Inc. (EOLS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 05/03/21
Evolus' (EOLS) CEO David Moatazedi on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/25/21
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business UpdateGlobeNewsWire • 03/24/21
Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business UpdateGlobeNewsWire • 03/23/21
Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimination of $127.4 Million of Debt and Milestone PaymentsGlobeNewsWire • 03/23/21